Jul 26 2012
Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the pricing of
its initial public offering of 5,000,000 shares of its common stock at
$10.00 per share, before underwriting discounts and commissions. All of
the common stock is being offered by Hyperion. In addition, the
underwriters have a 30-day option to purchase up to an additional
750,000 shares of common stock from Hyperion to cover over-allotments,
if any.
Shares of Hyperion's common stock will trade on the NASDAQ Global Select
Market under the symbol "HPTX" beginning on July 26, 2012. The offering
is expected to close on July 31, 2012, subject to customary closing
conditions.
How can microdialysis benefit drug development?